- Investing Ideas
- Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
7
Mid-Large Cap Stocks
7 companies
BioGaia
Market Cap: SEK 12.3b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 121.70
7D
-0.5%
1Y
18.3%
Vitrolife
Market Cap: SEK 13.0b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 95.90
7D
-1.6%
1Y
-32.8%
Camurus
Market Cap: SEK 32.2b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 548.00
7D
1.6%
1Y
-9.1%
AddLife
Market Cap: SEK 19.6b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 160.70
7D
1.9%
1Y
-19.1%
Bonesupport Holding
Market Cap: SEK 14.5b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 219.80
7D
-3.9%
1Y
-20.1%
BioArctic
Market Cap: SEK 26.8b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 295.80
7D
0.6%
1Y
48.3%
Swedish Orphan Biovitrum
Market Cap: SEK 150.4b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 435.00
7D
-2.0%
1Y
50.7%